Complications associated with antibiotic administration: neurological adverse events and interference with antiepileptic drugs

被引:24
|
作者
Esposito, Susanna [1 ]
Canevini, Maria Paola [2 ]
Principi, Nicola [3 ]
机构
[1] Univ Perugia, Pediat Clin, Piazza Lucio Severi 1, I-06132 Perugia, Italy
[2] Univ Milan, Dept Hlth Sci, San Paolo Hosp, Child Neurol Unit,Epilepsy Ctr, Milan, Italy
[3] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat, Pediat Highly Intens Care Unit, Milan, Italy
关键词
Antibiotics; Adverse events; Antiepileptic drugs; Antituberculosis drugs; Neurotoxicity; Drug interactions; BETA-LACTAM ANTIBIOTICS; ISONIAZID-INDUCED PSYCHOSIS; NERVOUS-SYSTEM TOXICITY; INDUCED NEUROTOXICITY; PERIPHERAL NEUROPATHY; OPTIC NEUROPATHY; CEFEPIME NEUROTOXICITY; NEUROMUSCULAR BLOCKADE; INDUCED ENCEPHALOPATHY; CLINICAL-IMPLICATIONS;
D O I
10.1016/j.ijantimicag.2017.01.027
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Antibiotic use is associated with toxic effects involving the peripheral and central nervous systems and it may interfere with antiepileptic drugs, causing significant variations in their serum levels and activity. Prompt identification of neurological complications during antibiotic therapy is important in order to make appropriate modifications to medication. Characteristics of the drug and the patient, including age and underlying diseases, may favour these complications. The main aim of this study was to review the neurological adverse events that may follow antibiotic administration, the mechanisms that cause them, and the possibility of prevention and treatment. Moreover, the interference of antibiotics with serum levels and the activity of antiepileptic drugs are discussed. The results demonstrate that antibiotic-associated adverse events involving the nervous system are relatively uncommon and are only rarely severe and irreversible, although neurotoxicity has been reported for several antibiotics. Moreover, for patients receiving antiepileptic drugs, monitoring of drug serum levels to avoid the risk of toxicity or inadequate therapy is mandatory during antibiotic treatment. Areas for future research include the effects of combined antibiotic therapies as well as multiple antiepileptic drugs in study populations with an adequate sample size, including neonates and infants, patients with pharmacoresistant epilepsy and elderly patients. (C) 2017 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 50 条
  • [31] Drug interactions and adverse events associated with antimycotic drugs used for invasive aspergillosis in hematopoietic SCT
    Egger, S. S.
    Meier, S.
    Leu, C.
    Christen, S.
    Gratwohl, A.
    Kraehenbuehl, S.
    Haschke, M.
    BONE MARROW TRANSPLANTATION, 2010, 45 (07) : 1197 - 1203
  • [32] Adverse events associated with sedatives, analgesics, and other drugs that provide patient comfort in the intensive care
    Riker, RR
    Fraser, GL
    PHARMACOTHERAPY, 2005, 25 (05): : 8S - 18S
  • [33] Adverse events after empiric antibiotic administration in dermatologic surgery: A global, propensity-matched, retrospective cohort study
    Lauck, Kyle C.
    Cho, Seo Won
    Rickstrew, Jace
    Tolkachjov, Stanislav N.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 90 (05) : 1065 - 1067
  • [34] Adverse events associated with molnupiravir: a real-world disproportionality analysis in food and drug administration adverse event reporting system
    Liang, Yankun
    Ma, Lin
    Wang, Yuting
    Zheng, Jingping
    Su, Ling
    Lyu, Jun
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [35] Analysis of Adverse Events Associated With Dental Local Anaesthetics Using Food and Drug Administration Adverse Event Reporting System Data
    Bayram, Ferit
    Akici, Ahmet
    Apari, Asli Melda
    Aydin, Volkan
    INTERNATIONAL DENTAL JOURNAL, 2025, 75 (03) : 1705 - 1712
  • [36] Dalfampridine Associated Serious Adverse Events: An Analysis of Data from the Food and Drug Administration's Adverse Event Reporting System
    Ahmed, Nehad J.
    Alahmari, Abdullah K.
    Alshehri, Ahmed M.
    Almalki, Ziyad S.
    LATIN AMERICAN JOURNAL OF PHARMACY, 2022, 41 (06): : 1195 - 1199
  • [37] Stevens-Johnson syndrome and toxic epidermal necrolysis with antiepileptic drugs: An analysis of the US Food and Drug Administration Adverse Event Reporting System
    Borrelli, Eric P.
    Lee, Erica Y.
    Descoteaux, Andrew M.
    Kogut, Stephen J.
    Caffrey, Aisling R.
    EPILEPSIA, 2018, 59 (12) : 2318 - 2324
  • [38] Neurological adverse events associated with PD-1/PD-L1 immune checkpoint inhibitors
    Zhou, Yanting
    Li, Hongyan
    FRONTIERS IN NEUROSCIENCE, 2023, 17
  • [39] Eye disorders associated with newer antiepileptic drugs: A real-world disproportionality analysis of FDA adverse event reporting system
    Hu, Weiping
    Chen, Li
    Li, Hailong
    Liu, Jinnan
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2022, 96 : 66 - 73
  • [40] Administration of aluminium to neonatal mice in vaccine-relevant amounts is associated with adverse long term neurological outcomes
    Shaw, C. A.
    Li, Y.
    Tomljenovic, L.
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2013, 128 : 237 - 244